AbbVie (NYSE: ABBV) announced the acquisition of Celsius Therapeutics, Inc. ("Celsius"), a privately held biotechnology company pioneering new...
The World Health Organization (WHO) has awarded Roche's human papillomavirus (HPV) test prequalification designations for use on the cobas 5800 System ...
Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of life science research, diagnostic, therapeutic develop...
Apollo Cancer Centres (ACC), in association with Accuray, a global provider of radiation therapy devices, announced the launch of India Sub-Contine...
Thermo Fisher Scientific Inc., the world leader in serving science, introduced the Thermo Scientific™ KingFisher™ PlasmidPro Maxi Process...
ANEW to explore therapeutics and specialty diagnostics utilizing the s-KL protein and will pursue other medical product development and commercial oppo...
Johnson & Johnson announced that it has successfully completed the acquisition of Proteologix, Inc., a privately-held biotechnology compa...
The VENTANA Kappa and Lambda Dual ISH mRNA Probe Cocktail assay is the first clinically approved in-situ hybridisation (ISH) test with the sensitivity ...
The solution, which includes the VENTANA DP 200 slide scanner, Roche's digital pathology workflow software and a display, is now cl...
Shanghai Junshi Biosciences , a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of nov...
Myocene, the Liège-based sportstech company developing a unique, cutting-edge device to objectively measure muscle fatigue, announced that i...
LIXTE Biotechnology Holdings, Inc. a clinical stage pharmaceutical company, today announced a collaboration with Roche and the Netherlands Cancer I...
AbbVie and FutureGen Biopharmaceutical (Beijing) Co., Ltd. announced a license agreement to develop FG-M701, a next generation TL1A antibody for th...
Biosplice Therapeutics, Inc. (“Biosplice”), a clinical-stage biotechnology company pioneering first-in-class therapeutics based on smal...
© 2025 Biopharma Boardroom. All Rights Reserved.
